JP2003004745A - Polymer latex for detecting target substance - Google Patents

Polymer latex for detecting target substance

Info

Publication number
JP2003004745A
JP2003004745A JP2001187037A JP2001187037A JP2003004745A JP 2003004745 A JP2003004745 A JP 2003004745A JP 2001187037 A JP2001187037 A JP 2001187037A JP 2001187037 A JP2001187037 A JP 2001187037A JP 2003004745 A JP2003004745 A JP 2003004745A
Authority
JP
Japan
Prior art keywords
target substance
substance
detecting
polymer latex
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001187037A
Other languages
Japanese (ja)
Inventor
Kazuyoshi Ito
一善 伊藤
Nobuyuki Akasaka
信幸 赤坂
Hideki Goto
英樹 後藤
Hideyuki Kuroda
英行 黒田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujikura Kasei Co Ltd
Original Assignee
Fujikura Kasei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujikura Kasei Co Ltd filed Critical Fujikura Kasei Co Ltd
Priority to JP2001187037A priority Critical patent/JP2003004745A/en
Publication of JP2003004745A publication Critical patent/JP2003004745A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for detecting a target substance in a sample to be tested which is simple to operate and has a high measurement sensitivity in a wide concentration range from a low concentration to a high concentration, and a polymer latex for executing the detection method. SOLUTION: The polymer latex for detecting the target substance in which carrier particles with a substance having affinity to the target substance in the sample immobilized are minutely aggregated, and the method for detecting the target substance in the sample to be tested are provided. In the method, the polymer latex for detecting the target substance and the sample to be tested are mixed, and an optical physical-properties value of the mixed liquid is measured.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、標的物質検出用の
新規なポリマーラテックス及びこれを用いた標的物質検
出方法に関する。
TECHNICAL FIELD The present invention relates to a novel polymer latex for detecting a target substance and a method for detecting a target substance using the same.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】近年、
病院や検査センター等においては、人員及び経費の節減
に伴い、臨床検査の自動化、簡便化、測定時間の短縮化
が図られている。一般的に使用される汎用性の自動分析
機に適する免疫学的測定法としては、不溶性担体を利用
して抗原又は抗体を定性又は定量する凝集法、特にラテ
ックス免疫凝集測定法が挙げられる。
2. Description of the Related Art In recent years,
At hospitals, test centers, etc., with the reduction of personnel and costs, clinical tests are being automated, simplified, and the measurement time is shortened. An immunological assay suitable for a commonly used general-purpose automatic analyzer includes an agglutination method in which an antigen or antibody is qualitatively or quantified using an insoluble carrier, particularly a latex immunoaggregation assay method.

【0003】これは、例えば抗原物質又は該抗原物質に
特異的に反応する抗体あるいはそのフラグメントを直接
ラテックスに担持させ、この担持された抗原物質又は抗
体に、被験試料を反応させ、ラテックスの凝集の程度を
光学的に測定することにより、測定対象物質を検出、定
量するものである。ここで、ラテックス免疫凝集法で被
験試料中の抗原物質を測定する場合に使用する抗体とし
ては、通常ポリクローナル抗体又はモノクローナル抗体
が用いられている。また、ラテックスとしては、例えば
ポリスチレン、又はスチレンとスチレンスルホン酸、ア
クリル酸、アクリル酸エステル、メタクリル酸エステ
ル、アセトニトリル等との共重合体等からなるラテック
ス(特開昭54−890195号公報)、含フッ素ポリ
マーラテックス(特開平1−266111号公報)等が
知られている。これらのポリマーラテックスは、安価
で、同品質のものが大量に得られるので、免疫測定法に
汎用されている。
This is because, for example, an antigen substance or an antibody or fragment thereof that specifically reacts with the antigen substance is directly carried on the latex, and a test sample is allowed to react with the carried antigen substance or antibody to prevent the latex from aggregating. The substance to be measured is detected and quantified by optically measuring the degree. Here, a polyclonal antibody or a monoclonal antibody is usually used as an antibody used when measuring an antigenic substance in a test sample by the latex immunoaggregation method. Examples of the latex include polystyrene or a latex made of styrene and a copolymer of styrene and styrenesulfonic acid, acrylic acid, acrylic acid ester, methacrylic acid ester, acetonitrile or the like (JP-A-54-890195). Fluoropolymer latex (Japanese Patent Laid-Open No. 1-266111) and the like are known. These polymer latices are inexpensive and can be obtained in large quantities in the same quality, and are therefore widely used in immunoassays.

【0004】しかしながら、抗原物質又は抗体を直接ラ
テックスに担持させた免疫凝集法における測定感度は、
十分高いとは言い難い。特に、微量抗原又は抗体の測定
に対しては、感度が低く、その改善が望まれていた。
However, the measurement sensitivity in the immunoaggregation method in which the antigen substance or antibody is directly carried on the latex is
It is hard to say that it is high enough. In particular, the sensitivity is low for the measurement of trace antigens or antibodies, and improvement thereof has been desired.

【0005】また、ラテックス凝集免疫測定法の測定感
度を上げるため、被験試料中の抗原物質に対する抗体を
直接ラテックスに担持するのでなく、該抗体に対する第
二抗体を介してラテックスに担持する方法が知られてい
る(特開平9−318629号公報)が、かかる方法
は、操作が煩雑であるという問題があった。
Further, in order to increase the measurement sensitivity of the latex agglutination immunoassay, a method is known in which an antibody against an antigenic substance in a test sample is not directly carried on the latex but is carried on the latex via a second antibody against the antibody. However, this method has a problem that the operation is complicated.

【0006】したがって、本発明は、操作が簡便で、低
濃度から高濃度にわたる広い濃度範囲において高い測定
感度が得られる被験試料中の標的物質の検出方法及びか
かる検出方法を実施するためのポリマーラテックスを提
供することを目的とする。
Therefore, the present invention provides a method for detecting a target substance in a test sample which is easy to operate and has high measurement sensitivity in a wide concentration range from low concentration to high concentration, and a polymer latex for carrying out such detection method. The purpose is to provide.

【0007】[0007]

【課題を解決するための手段】本発明者らは、上記目的
を達成すべく鋭意研究した結果、被験試料中の標的物質
に親和性を有する物質が固定化された担体粒子を、微凝
集させて測定に供することにより、低濃度から高濃度に
わたる広い濃度範囲において高感度で標的物質を測定す
ることができ、かつ操作が簡便であることを見出し、本
発明を完成した。
Means for Solving the Problems As a result of intensive studies aimed at achieving the above object, the inventors of the present invention microaggregated carrier particles having a substance having an affinity for a target substance in a test sample immobilized thereon. It was found that the target substance can be measured with high sensitivity in a wide concentration range from low concentration to high concentration and the operation is simple, and the present invention has been completed.

【0008】すなわち、本発明は、被験試料中の標的物
質に親和性を有する物質が固定化された担体粒子を、微
凝集させてなることを特徴とする標的物質検出用ポリマ
ーラテックスを提供するものである。本発明はまた、被
験試料中の標的物質の検出方法であって、かかる標的物
質検出用ポリマーラテックスと被験試料を混合し、混合
液の光学的物性値を測定することを特徴とする、被験試
料中の標的物質の検出方法を提供するものである。
[0008] That is, the present invention provides a polymer latex for detecting a target substance, which is characterized in that carrier particles, to which a substance having an affinity for the target substance in a test sample is immobilized, are finely aggregated. Is. The present invention is also a method for detecting a target substance in a test sample, wherein the target substance detection polymer latex is mixed with the test sample, and the optical property value of the mixed solution is measured. The present invention provides a method for detecting a target substance therein.

【0009】[0009]

【発明の実施の形態】本発明において用いられる担体粒
子としては、粒径が比較的一定であり、また、工業的に
一定の品質、性能のものを大量生産することができるも
のであれば、特に制限はない。ポリマーの種類に特に制
限はなく、例えばスチレン、塩化ビニル、アクリロニト
リル、酢酸ビニル、アクリル酸エステル、メタクリル酸
エステル等のビニル系モノマーの単一重合体や共重合
体;スチレン−ブタジエン共重合体、メチルメタクリレ
ート−ブタジエン共重合体等のブタジエン系共重合体等
が挙げられる。これらのうち、抗体等の物質の吸着性に
優れており、かつ、生物学的活性を長期間保持できる等
の観点から、ポリスチレン系のポリマー粒子が好まし
い。担体粒子の粒径は、好ましくは0.01〜10μm
が好ましく、0.03〜1μmが特に好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION As the carrier particles used in the present invention, as long as the carrier particles have a relatively constant particle size and can be mass-produced with industrially constant quality and performance, There is no particular limitation. The type of polymer is not particularly limited, and examples thereof include homopolymers and copolymers of vinyl monomers such as styrene, vinyl chloride, acrylonitrile, vinyl acetate, acrylic acid ester, and methacrylic acid ester; styrene-butadiene copolymer, methyl methacrylate. -Butadiene-based copolymers such as butadiene copolymer and the like can be mentioned. Of these, polystyrene-based polymer particles are preferable from the viewpoints of excellent adsorbability of substances such as antibodies, and long-term retention of biological activity. The particle size of the carrier particles is preferably 0.01 to 10 μm
Is preferable, and 0.03 to 1 μm is particularly preferable.

【0010】本発明において、検出する標的物質として
は、特に制限はないが、各種疾病やアレルギー等の原因
物質、病原菌、生理活性物質、それらの抗体等が挙げら
れる。具体的には、免疫グロブリン(例えば、ヒト及び
動物免疫グロブリン、変性免疫グロブリン)、各種ウイ
ルス抗原(例えば、肝炎ウイルス関連抗原、風疹HA抗
原等)、種々の細菌、真菌、毒素等の微生物抗原(例え
ば、トキソプラズマ、梅毒トレポネーマ等)、各種血漿
タンパク成分(例えば、α−フェトプロテイン、C反応
性タンパク(CRP)、アルブミン補体成分等)、各種
ホルモン(例えば、エストロゲン、ヒト絨毛性ゴナドト
ロピン、(HCG)等)、抗体(例えば、抗CEA(ca
rcinoembryonic antigen)抗体、抗反応性タンパク抗
体、抗フィブリノーゲン抗体、抗γ−グロブリン抗体
等)、ホルモン受容体(例えば、甲状腺刺激ホルモンリ
セプター、HCGリセプター等)、酵素(例えば、アル
カリフォスファターゼ、コリンエステラーゼ等)、基質
(例えば、コレステロール、尿酸等)、ヘモグロビン誘
導体、糖誘導体(例えば糖化合物、糖タンパク質等)が
挙げられる。
In the present invention, the target substance to be detected is not particularly limited, but examples thereof include causative substances of various diseases and allergies, pathogenic bacteria, physiologically active substances, antibodies thereof and the like. Specifically, immunoglobulins (eg, human and animal immunoglobulins, denatured immunoglobulins), various viral antigens (eg, hepatitis virus-related antigens, rubella HA antigens, etc.), microbial antigens such as various bacteria, fungi, toxins ( For example, Toxoplasma, Treponema pallidum, etc.), various plasma protein components (eg, α-fetoprotein, C-reactive protein (CRP), albumin complement component, etc.), various hormones (eg, estrogen, human chorionic gonadotropin, (HCG)) Etc.), antibodies (eg anti-CEA (ca
rcinoembryonic antigen) antibody, anti-reactive protein antibody, anti-fibrinogen antibody, anti-γ-globulin antibody etc.), hormone receptor (eg thyroid stimulating hormone receptor, HCG receptor etc.), enzyme (eg alkaline phosphatase, cholinesterase etc.), Substrates (eg, cholesterol, uric acid, etc.), hemoglobin derivatives, sugar derivatives (eg, sugar compounds, glycoproteins, etc.) can be mentioned.

【0011】本発明において、「標的物質に親和性を有
する物質」とは、上記標的物質と、抗原−抗体反応、酵
素−基質反応又はリガンド−受容体反応等によって親和
性を有する物質が挙げられる。
In the present invention, the "substance having an affinity for a target substance" includes a substance having an affinity for the above-mentioned target substance by an antigen-antibody reaction, an enzyme-substrate reaction, a ligand-receptor reaction or the like. .

【0012】標的物質に親和性を有する物質を、ポリマ
ー粒子に担持させるには、物理的に吸着させる場合には
両者を単に混合させればよい。また、化学的に結合させ
る場合には、ポリマー粒子又は標的物質に親和性を有す
る物質の表面に存在する官能基を利用して、又は適当な
官能基を有するスペーサを介して結合させることができ
る。
In order to support the substance having an affinity for the target substance on the polymer particles, they may be simply mixed when they are physically adsorbed. Further, in the case of chemically bonding, the functional group existing on the surface of the polymer particle or the substance having an affinity for the target substance can be utilized, or the spacer can be bonded through a spacer having an appropriate functional group. .

【0013】本発明の標的物質の検出方法は、微凝集し
たポリマーラテックスを被験試料と混合し、混合液の光
学的物性値を測定するものである。微凝集したポリマー
ラテックスを用いることにより、低濃度から高濃度にわ
たる広い濃度範囲において高感度で標的物質を測定する
ことができる。微凝集させることによりなぜ高感度で測
定できるかについては、必ずしも明確ではないが、かか
るポリマーラテックスが光をよく散乱させること、すな
わち散乱強度が大きくなることによるのではないかと考
えられる。すなわち、ポリマーラテックスの凝集に、系
の濁度がより敏感に対応することによると考えられる。
The method for detecting a target substance according to the present invention is to mix finely aggregated polymer latex with a test sample and measure the optical properties of the mixed solution. By using the finely aggregated polymer latex, the target substance can be measured with high sensitivity in a wide concentration range from low concentration to high concentration. Although it is not always clear why the measurement can be performed with high sensitivity by microaggregation, it is considered that the polymer latex scatters light well, that is, the scattering intensity increases. That is, it is considered that the turbidity of the system more sensitively responds to the aggregation of the polymer latex.

【0014】本発明における担体粒子の微凝集の大きさ
は、低濃度から高濃度にわたる広い濃度範囲において高
感度で標的物質を測定することができる大きさである
が、具体的には、平均粒径が0.01〜10μmである
ことが好ましく、0.03〜1μmであることが特に好
ましい。0.01μm未満及び10μm超では、散乱強
度が十分に向上せず、測定感度を向上させることができ
ない。
The size of the fine agglomeration of the carrier particles in the present invention is such that the target substance can be measured with high sensitivity in a wide concentration range from a low concentration to a high concentration. The diameter is preferably 0.01 to 10 μm, and particularly preferably 0.03 to 1 μm. If it is less than 0.01 μm or exceeds 10 μm, the scattering intensity is not sufficiently improved, and the measurement sensitivity cannot be improved.

【0015】担体粒子を微凝集させる手段としては、標
的物質に親和性を有する物質がタンパク質である場合、
例えばpHやイオン強度等を変化させ、必要に応じて撹
拌等する方法等も可能である。かかる方法は、担体粒子
同士を微凝集させるものであり、pHやイオン強度等の
変化量、撹拌強度等を制御することにより、比較的容易
に微凝集を生成させることができる。しかしながら、上
記方法では、酸、アルカリ、あるいは塩等を添加する必
要があり、これら化合物の存在は、その後の標的物質の
検出に障害となる可能性がある。また、これらを中和し
たり除去するのは操作が煩雑である。したがって、本発
明においては、以下の方法で行うことがより好ましい。
As means for finely agglomerating carrier particles, when the substance having an affinity for the target substance is a protein,
For example, a method of changing pH, ionic strength, or the like, and stirring the mixture, if necessary, is also possible. In this method, the carrier particles are finely aggregated, and the fine aggregation can be relatively easily generated by controlling the amount of change in pH, ionic strength, etc., the stirring strength, and the like. However, in the above method, it is necessary to add an acid, an alkali, a salt, or the like, and the presence of these compounds may hinder the subsequent detection of the target substance. Further, the operation is complicated to neutralize or remove them. Therefore, in the present invention, the following method is more preferable.

【0016】標的物質に親和性を有する物質を担持した
担体粒子に、標的物質を作用させる。これにより、標的
物質が担体粒子表面に、標的物質に親和性を有する物質
を介して結合する。さらに、場合によっては、標的物
質、標的物質に親和性を有する物質は、担体粒子間を架
橋する。その結果、担体粒子の微凝集が生じる。かかる
方法によれば、微凝集の生成に用いるのは、標的物質の
みであるので、上記方法のような煩雑な操作を必要とし
ない。微凝集の大きさは、作用させる標的物質の量、さ
らに必要に応じて作用させるときの温度、時間等により
制御することができる。かかる担体粒子を微凝集させた
ポリマーラテックスは、一般に広く用いられているラテ
ックス凝集法、特に診断試薬用に有効に用いることがで
きる。
The target substance is allowed to act on carrier particles carrying a substance having an affinity for the target substance. As a result, the target substance is bound to the surface of the carrier particles via the substance having an affinity for the target substance. Further, in some cases, the target substance and the substance having an affinity for the target substance crosslink between the carrier particles. As a result, fine agglomeration of carrier particles occurs. According to such a method, since only the target substance is used to generate the microaggregates, a complicated operation as in the above method is not required. The size of the micro-aggregates can be controlled by the amount of the target substance to act and, if necessary, the temperature, time and the like when the substance acts. The polymer latex obtained by finely agglomerating such carrier particles can be effectively used for the latex agglutination method which is generally widely used, particularly for diagnostic reagents.

【0017】なお、担体粒子には、複数種類の物質を担
持させてもよい。すなわち、まず、1つの物質に、それ
に親和性を有し、担体粒子に担持された物質を反応させ
て、微凝集を生成させる。次いで、標的物質に、標的物
質に親和性を有し、同様に担体粒子に担持された物質を
反応させることにより、微凝集させるのに用いた物質と
は異なる物質を検出することができる。
The carrier particles may carry a plurality of types of substances. That is, first, one substance is caused to react with a substance that has an affinity for it and is carried by the carrier particles to generate fine aggregates. Then, by reacting the target substance with a substance that has an affinity for the target substance and is similarly supported by the carrier particles, a substance different from the substance used for the microaggregation can be detected.

【0018】次に、本発明の標的物質の検出方法につい
て説明する。まず、微凝集したポリマーラテックスを被
験試料と混合し、適宜撹拌する。標的物質が存在する場
合には、凝集が生じる。かかる凝集反応の条件は、凝集
反応が起こり得る条件であれば特に制限はないが、温度
は25〜37℃の恒温下、反応時間は5秒〜15分間が
好ましい。反応溶液に特に制限はないが、例えばリン酸
緩衝液、グリシン緩衝液、トリス塩酸緩衝液、グッドの
緩衝液等が挙げられる。媒体のpHは、好ましくは5.
5〜8.5、特に好ましくは6.5〜8.0である。混
合後のポリマーラテックスの濃度は、標的物質の性質、
予想される存在量、得られる散乱光強度等を考慮して適
宜決定することができるが、一般的には、ラテックス粒
子換算で、0.01〜10重量%が好ましく、0.1〜
1重量%が特に好ましい。
Next, the method for detecting the target substance of the present invention will be described. First, the polymer latex that has been finely aggregated is mixed with a test sample and appropriately stirred. Aggregation occurs when the target substance is present. The conditions of the agglutination reaction are not particularly limited as long as the agglutination reaction can occur, but the temperature is preferably a constant temperature of 25 to 37 ° C., and the reaction time is preferably 5 seconds to 15 minutes. The reaction solution is not particularly limited, and examples thereof include a phosphate buffer solution, a glycine buffer solution, a Tris hydrochloric acid buffer solution, and Good's buffer solution. The pH of the medium is preferably 5.
It is 5 to 8.5, and particularly preferably 6.5 to 8.0. The concentration of the polymer latex after mixing depends on the properties of the target substance,
It can be appropriately determined in consideration of the expected abundance, the intensity of scattered light to be obtained, etc., but generally it is preferably 0.01 to 10% by weight in terms of latex particles, and 0.1 to 10% by weight.
1% by weight is particularly preferred.

【0019】また、反応溶液には、安定剤としてウシ血
清アルブミン、ショ糖等;測定感度向上剤としてポリエ
チレングリコール、デキストラン等の水溶性多糖類;防
腐剤としてアジ化ナトリウム;塩濃度調整剤として塩化
ナトリウム等の添加剤を適宜添加することができる。
In the reaction solution, bovine serum albumin, sucrose and the like as stabilizers; water-soluble polysaccharides such as polyethylene glycol and dextran as measuring sensitivity improving agents; sodium azide as an antiseptic; chloride as a salt concentration adjusting agent. Additives such as sodium can be added as appropriate.

【0020】次いで、混合液の光学的物性値を測定す
る。凝集を検出するための具体的な光学的測定法に特に
制限はないが、例えば比濁分析法、比ろう分析法等が挙
げられる。かかる方法を用い、予め作成した検量線か
ら、被験試料中の標的物質の濃度を容易に検出すること
ができる。被験試料としては、例えば血液、血清、体
液、尿、便等が挙げられる。
Next, the optical properties of the mixed solution are measured. The specific optical measurement method for detecting agglutination is not particularly limited, and examples thereof include nephelometry and nephelometry. Using such a method, the concentration of the target substance in the test sample can be easily detected from the calibration curve prepared in advance. Examples of test samples include blood, serum, body fluid, urine, feces and the like.

【0021】[0021]

【実施例】次に実施例を示して本発明をさらに詳細に説
明するが、本発明は以下の実施例に限定されるものでは
ない。
EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples.

【0022】実施例1 (1)抗ヒトCRPヤギポリクローナル抗体感作粒子の
調製 抗ヒトCRPヤギポリクローナル抗体(Interna
tional Immunology Corp.製:
以下、「CRP抗体」という)を2.0mg/mLの濃
度で10mMのトリス塩酸緩衝液(pH7.2)に溶解
した液10.0mLに、平均粒径が55nmのポリスチ
レン粒子(藤倉化成(株)製:固形分1重量%)10.
0mLを添加し、4℃で60分間撹拌した。次いで、こ
の液にウシ血清アルブミン(以下、「BSA」という)
を1重量%含有する0.1Mリン酸緩衝液(pH7.
0:以下、「PBS」という)を添加し、4℃で60分
間撹拌した後、20000rpmで60分間遠心分離し
て洗浄した。洗浄操作は3回行った。得られた沈殿物に
BSAを1重量%含有するPBS10mLを添加し、感
作粒子を懸濁した後、超音波破砕機にて分散処理を行
い、固形分0.1%(W/V)のCRP抗体感作粒子を
調製した。 (2)ラテックス試液の調製 (1)で調製したCRP抗体感作粒子10.0mLに対
して、ヒトCRP(オリエンタル酵母工業(株)製)を
1.0μg添加し、4℃で60分間撹拌した後、1昼夜
静置してラテックス試液とした。 (3)試料の調製 ヒトプール血清に、ヒトCRPを所定濃度となるように
溶解したものを試料とした。 (4)測定 PBS 300μLと、上記(3)で調製した試料3μ
Lとを混合し、37℃で5分間予備加温を行った後、こ
れにさらに上記(2)で調製したラテックス試液100
μLを加えて反応を開始させ、該ラテックス試液添加直
後からの5分間の吸光度変化量を測定した。測定装置
は、自動汎用測定機日立7020形(日立製作所(株)
製)を使用し、測定波長570nm、測定温度37℃で
測定を行った。結果を図1に示す。
Example 1 (1) Preparation of anti-human CRP goat polyclonal antibody sensitized particles Anti-human CRP goat polyclonal antibody (Interna)
regional Immunology Corp. Made by:
Hereinafter, "CRP antibody") was dissolved in 10 mM Tris-HCl buffer (pH 7.2) at a concentration of 2.0 mg / mL to 10.0 mL of a solution, and polystyrene particles having an average particle size of 55 nm (Fujikura Chemical Co., Ltd. ): Solid content 1% by weight) 10.
0 mL was added and stirred at 4 ° C. for 60 minutes. Next, bovine serum albumin (hereinafter referred to as "BSA") is added to this solution.
0.1M phosphate buffer solution (pH 7.
0: hereinafter, referred to as “PBS”) was added, and the mixture was stirred at 4 ° C. for 60 minutes and then centrifuged at 20000 rpm for 60 minutes for washing. The washing operation was performed 3 times. To the obtained precipitate, 10 mL of PBS containing 1% by weight of BSA was added to suspend the sensitized particles, followed by dispersion treatment with an ultrasonic crusher to obtain a solid content of 0.1% (W / V). CRP antibody-sensitized particles were prepared. (2) Preparation of latex reagent 1.0 μg of human CRP (manufactured by Oriental Yeast Co., Ltd.) was added to 10.0 mL of the CRP antibody-sensitized particles prepared in (1), and the mixture was stirred at 4 ° C. for 60 minutes. After that, the solution was allowed to stand for one day to prepare a latex test solution. (3) Preparation of sample A sample was prepared by dissolving human CRP in human pool serum to a predetermined concentration. (4) 300 μL of measurement PBS and 3 μ of the sample prepared in (3) above
After mixing with L and preheating at 37 ° C. for 5 minutes, the latex reagent solution 100 prepared in (2) above was further added.
The reaction was started by adding μL, and the amount of change in absorbance for 5 minutes immediately after the addition of the latex reagent solution was measured. The measuring device is an automatic general-purpose measuring machine Hitachi 7020 type (Hitachi Ltd.)
(Manufactured by Mitsui Chemicals Co., Ltd.) was used at a measurement wavelength of 570 nm and a measurement temperature of 37 ° C. The results are shown in Fig. 1.

【0023】比較例1 実施例1における(2)ラテックス試液の調製で、CR
P抗体感作粒子にヒトCRPを添加せず、そのままラテ
ックス試液として使用したこと以外は、実施例1と同様
に測定を行った。結果を図1に示す
Comparative Example 1 (2) In the preparation of the latex reagent solution (2) in Example 1, CR was used.
The measurement was performed in the same manner as in Example 1 except that human CRP was not added to the P antibody-sensitized particles and the particles were used as a latex reagent solution as it was. The results are shown in Figure 1.

【0024】図1から明らかなように、CRP抗体感作
粒子にCRPを作用させて、微凝集させたラテックス試
液を用いると、低濃度域での測定感度を上昇させること
が可能となる。
As is clear from FIG. 1, when CRP is allowed to act on the CRP antibody-sensitized particles to use the latex reagent solution which is finely aggregated, it becomes possible to increase the measurement sensitivity in a low concentration range.

【0025】[0025]

【発明の効果】本発明の標的物質検出用ポリマーラテッ
クスを用いることにより、従来の方法に比べて、測定対
象物質の濃度に応じて十分な測定感度を有し、しかも低
濃度域から高濃度域にわたる広い測定範囲において、高
精度でその濃度を測定することができる。
EFFECTS OF THE INVENTION By using the polymer latex for detecting a target substance of the present invention, it has sufficient measurement sensitivity depending on the concentration of the substance to be measured, and has a low concentration range to a high concentration range as compared with the conventional method. The concentration can be measured with high accuracy in a wide measurement range over the range.

【図面の簡単な説明】[Brief description of drawings]

【図1】 実施例と比較例による、CRP抗原濃度に対
する吸光度を示す図である。
FIG. 1 is a diagram showing the absorbance with respect to the CRP antigen concentration in Examples and Comparative Examples.

フロントページの続き (72)発明者 後藤 英樹 埼玉県北葛飾郡鷲宮町桜田5丁目13番1号 藤倉化成株式会社開発研究所内 (72)発明者 黒田 英行 埼玉県北葛飾郡鷲宮町桜田5丁目13番1号 藤倉化成株式会社開発研究所内 Fターム(参考) 2G054 AA06 AB04 BA03 BA04 BB13 CA21 CD04 EA04 EA09 EB01 EB05 GA03 GB01 Continued front page    (72) Inventor Hideki Goto             5-13-1 Sakurada, Washinomiya-cho, Kitakatsushika-gun, Saitama Prefecture               Fujikura Kasei Co., Ltd. (72) Inventor Hideyuki Kuroda             5-13-1 Sakurada, Washinomiya-cho, Kitakatsushika-gun, Saitama Prefecture               Fujikura Kasei Co., Ltd. F-term (reference) 2G054 AA06 AB04 BA03 BA04 BB13                       CA21 CD04 EA04 EA09 EB01                       EB05 GA03 GB01

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 被験試料中の標的物質に親和性を有する
物質が固定化された担体粒子を、微凝集させてなること
を特徴とする標的物質検出用ポリマーラテックス。
1. A polymer latex for detecting a target substance, comprising carrier particles, to which a substance having an affinity for the target substance in a test sample is immobilized, which are finely aggregated.
【請求項2】 標的物質を、該標的物質に親和性を有す
る物質に作用させることにより、担体粒子を微凝集させ
ることを特徴とする請求項1記載の標的物質検出用ポリ
マーラテックス。
2. The polymer latex for detecting a target substance according to claim 1, wherein carrier particles are finely aggregated by causing the target substance to act on a substance having an affinity for the target substance.
【請求項3】 標的物質に親和性を有する物質が、抗原
−抗体反応、酵素−基質反応、又はリガンド−受容体反
応により、標的物質に親和性を有するものである請求項
1又は2記載の標的物質検出用ポリマーラテックス。
3. The substance according to claim 1 or 2, wherein the substance having an affinity for the target substance has an affinity for the target substance through an antigen-antibody reaction, an enzyme-substrate reaction, or a ligand-receptor reaction. Polymer latex for target substance detection.
【請求項4】 診断試薬用である請求項1〜3のいずれ
か1項に記載の標的物質検出用ポリマーラテックス。
4. The polymer latex for detecting a target substance according to claim 1, which is used for a diagnostic reagent.
【請求項5】 凝集の大きさが、0.01〜10μmで
ある請求項1〜4のいずれか1項に記載の標的物質検出
用ポリマーラテックス。
5. The polymer latex for detecting a target substance according to claim 1, wherein the aggregate size is 0.01 to 10 μm.
【請求項6】 被験試料中の標的物質の検出方法であっ
て、請求項1〜5のいずれか1項に記載の標的物質検出
用ポリマーラテックスと被験試料を混合し、混合液の光
学的物性値を測定することを特徴とする、被験試料中の
標的物質の検出方法。
6. A method for detecting a target substance in a test sample, which comprises mixing the polymer latex for detecting a target substance according to any one of claims 1 to 5 with a test sample to obtain optical properties of the mixed solution. A method for detecting a target substance in a test sample, which comprises measuring a value.
JP2001187037A 2001-06-20 2001-06-20 Polymer latex for detecting target substance Pending JP2003004745A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001187037A JP2003004745A (en) 2001-06-20 2001-06-20 Polymer latex for detecting target substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001187037A JP2003004745A (en) 2001-06-20 2001-06-20 Polymer latex for detecting target substance

Publications (1)

Publication Number Publication Date
JP2003004745A true JP2003004745A (en) 2003-01-08

Family

ID=19026393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001187037A Pending JP2003004745A (en) 2001-06-20 2001-06-20 Polymer latex for detecting target substance

Country Status (1)

Country Link
JP (1) JP2003004745A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008256457A (en) * 2007-04-03 2008-10-23 Olympus Corp Aggregation inspection method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02143163A (en) * 1988-11-25 1990-06-01 Sekisui Chem Co Ltd Reagent for immunoassay and immunoassay using this reagent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02143163A (en) * 1988-11-25 1990-06-01 Sekisui Chem Co Ltd Reagent for immunoassay and immunoassay using this reagent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008256457A (en) * 2007-04-03 2008-10-23 Olympus Corp Aggregation inspection method

Similar Documents

Publication Publication Date Title
JP4668768B2 (en) Immunoassay method and non-specific reaction suppression method
JPS60256057A (en) Immunological measurement
JPH068822B2 (en) Protected binding assay
JP4704662B2 (en) Immunological latex turbidimetric analysis method and reagent
JP3623657B2 (en) Nonspecific reaction inhibitor, immunoassay reagent and immunoassay method
JP4086266B2 (en) Immunoassay method
JP3771413B2 (en) Antiphospholipid antibody measuring reagent, method for producing the same, and antiphospholipid antibody measuring method
JP2682697B2 (en) Immunoassay reagents and immunoassays
JP3220546B2 (en) Method for measuring antigen or antibody in the presence of immune complex
US6927071B2 (en) Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
JP2003004745A (en) Polymer latex for detecting target substance
JP2004191332A (en) Immunological analysis reagent and immunological analysis method
JPH0712818A (en) Immunological detection
JPH03186761A (en) Dry type immunoassay analysis element containing signal dispersed bead
JPH11344494A (en) Immunological agglutination reaction reagent and method for suppressing prozone phenomenon by using the same
JP4556605B2 (en) Target substance measurement method and reagent
JP2003344410A (en) Immuno-measurement reagent and immuno-measurement method
JP2745705B2 (en) Antigen / antibody assay
JP3048306B2 (en) Fibrin degradation product and / or fibrinogen degradation product measuring reagent and method for quantifying the same
JP2000146974A (en) Immunoassay
JPH09304386A (en) Manufacture of immunity diagnostic drug and immunity diagnostic drug obtained
JP2000275245A (en) Immunoassay reagent and immunoassay
JP2002310874A (en) Measurement reagent and measurement method for quartz resonator
JPH10282101A (en) Method and kit for measurement
JPH09304388A (en) Quantitative method for human immunoglobulin e and measuring kit

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080310

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100202

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100608